[1]
|
E. M. Sillos, J. L. Shenep, G. A. Burghen, C. H. Pui, F. G. Behm and J. T. Sandlund, “Lactic Acidosis: A Metabolic Complication of Hematologic Malignancies: Case Report and Review of the Literature,” Cancer, Vol. 92, No. 9, 2001, pp. 2237-2246.doi:10.1002/1097-0142(20011101)92:9<2237::AID-CNCR1569>3.0.CO;2-9
|
[2]
|
J. Block, W. Bronson and W. Bell, “Metabolic Abnormalities of Lactic Acid in Burkitt-type Lymphoma with Malignant Effusion,” Annals of Internal Medicine, Vol. 65, No. 1, 1966, pp. 101-108.
|
[3]
|
S. Sebastian and U. W. Kenkare, “Insulin-Like Growth Factor 1 Induces Tumor Hexokinase RNA Expression in Cancer Cell,” Biochemical and Biophysical Research Communications, Vol. 235, No. 2, 1997, pp. 389-393.doi:10.1006/bbrc.1997.6797
|
[4]
|
S. P. Mathupala, A. Rempel, P. L. Pedersen, “Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-Translational, and Mutational Events that Lead to a Critical Role for Type II Hexokinase,” Journal of Bioenergetics and Biomembranes, Vol. 29, No. 4, 1997, pp. 339-343. doi:10.1023/A:1022494613613
|
[5]
|
J. P. Ruiz, A. K. Singh and P. Hart, “Type B Lactic Acidosis Secondary to Malignancy: Case Report, Review of Published Cases, Insights into Pathogenesis, and Prospects for Therapy,” The Scientific World Journal, Vol. 11, 2011, pp. 1316-1324.doi:10.1100/tsw.2011.125
|
[6]
|
S. Sariban-Sohraby, I. T. Magrath and R. S. Balaban, “Comparison of Energy Metabolism in Human Normal and Neoplastic (Burkitt’s Lymphoma) Lymphoid Cells,” Cancer Research, Vol. 43, No. 10, 1983, pp. 4662-4664.
|
[7]
|
R. G. Narins, G. G. Krishna, J. Yee, et al., “The Metabolic Acidosis,” In: R. G. Narins, Ed., Maxwell & Kleeman’s Clinical Disorders of Fluid and Electrolyte Metabolism, 5th Edition, McGraw-Hill, Inc., New York, 1994. pp 769-825
|
[8]
|
J. Svahn, M. Schiaffino, U. Caruso, M. Calvillo, G. Min- niti and C. Dufour, “Type B Lactic Acidosis Secondary to Malignancy: Case Report, Review of Published Cases, Insights into Pathogenesis, and Prospects for Therapy,” Journal of Pediatric Hematology/Oncology, Vol. 25, 2003, pp. 965-968.doi:10.1097/00043426-200312000-00012
|
[9]
|
S. Osorio, C. Bernis and R. de La Camara, “Lactic Acidosis in Non-Hodgkin’s Lymphoma and Response to Chemotherapy,” Haematologica, Vol. 87, No. 2, 2002, p. 5
|
[10]
|
A. S. Friedenberg, D. E. Brandoff and F. J. Schiffman, “Type B Lactic Acidosis as a Severe Metabolic Complication in Lymphoma and Leukemia: A Case Series from a Single Institution and Literature Review,” Medicine (Baltimore), Vol. 86, No. 4, 2007, pp. 225-232. doi:10.1097/MD.0b013e318125759a
|
[11]
|
J. Durig, W. Fiedler, M. de Wit, M. Steffen and D. Hossfeld, “Lactic Acidosis and Hypoglycemia in a Patient with High-Grade Non-Hodgkin’s Lymphoma and Elevated Circulating TNF-a,” Annals of Hematology, Vol. 72, No. 2, 1996, pp. 97-99. doi:10.1007/BF00641317
|
[12]
|
H. Werner and D. LeRoith, “The Role of the Insulin-Like Growth Factor System in Human Cancer,” Advances in Cancer Research, Vol. 68, 1996, pp. 183-223. doi:10.1016/S0065-230X(08)60354-1
|
[13]
|
T. A. Yap, D. Olmos, L. R. Molife and J. S. de Bono, “Targeting the Insulin-Like Growth Factor Signaling Pathway: Figitumumab and Other Novel Anticancer Strategies,” Expert Opinion Investigatinal Drugs, Vol. 20, No. 9, 2011, pp. 1293-1304. doi:10.1517/13543784.2011.602630
|
[14]
|
J. J. Glasheen and M. D. Sorensen, “Burkitt’s Lymphoma Presenting with Lactic Acidosis and Hypoglycemia—A Case Presentation,” Leukemia & Lymphoma, Vol. 46, No. 2, 2005, pp. 281-283. doi:10.1080/10428190400016723
|
[15]
|
M. López Rodríguez, E. Vázquez Munoz, J. Gómez Cerezo, B. Pagán Munoz, E. Ruiz Bravo-Burguillos, F. J. Barbado Hernández, “Lactic Acidosis, Severe Hypoglycemia and Hepatosplenomegaly,” Revista Clínica Espanola, Vol. 207, No. 10, 2007, pp. 521-522. doi:10.1157/13111552
|
[16]
|
T. Révész, K. Obeid and C. Mpofu, “Severe Lactic Acidosis and Renal Involvement in a Patient with Relapsed Burkitt’s Lymphoma,” Journal of Pediatric Hematology/Oncology, Vol. 12, No. 3, 1995, pp. 283-288. doi:10.3109/08880019509029570
|
[17]
|
C. Bergin, R. Pilkington, C. McCreary, F. Mulcahy and V. Crowley, “Lactic Acidosis, Non-Hodgkins Lymphoma and the Acquired Immunodeficiency Syndrome,” Genitourinary Medicine, Vol. 70, No. 2, 1994, pp. 148-149. doi:10.1136/sti.70.2.148
|
[18]
|
B. Mégarbane, F. Bruneel, V. Andrieu, M. Wolff and B. Régnier, “The Last Voyage of a Globe-Trotter,” La Revue de Médecine Interne, Vol. 21, Suppl. 3, 2000, pp. 340s-342s. doi:10.1016/S0248-8663(00)89263-2
|
[19]
|
P. Rouzet, H. Rubie, A. Robert, A. Dutour, J. P. Olives, C. Scipioni, J. Guitard and C. Régnier, “Severe Hyperlactacidemia in 2 Children Treated for Malignant Tumors. Role of Vitamin B1,” Archives Francaises de Pédiatrie, Vol. 48, No. 6, 1991, pp. 423-426.
|
[20]
|
K. Kulkarni, S. Kaur, A. Sibal, N. Jerath and L. S. Arya, “Severe Lactic Acidosis, Hypertriglyceridemia, and Extensive Axial Skeleton Involvement in a Case of Disseminated Burkitt’s Lymphoma,” International Journal of Hematology, Vol. 91, No. 3, 2010, pp. 546-548.doi:10.1007/s12185-010-0534-8
|
[21]
|
M. V. Rastogi, N. Desai and J. B. Quintos, “Non-Islet-Cell Tumor Hypoglycemia and Lactic Acidosis in a Child with Congenital HIV and Burkitt’s Lymphoma,” Journal of Pediatric Endocrinology & Metabolism, Vol. 21, No. 8, 2008, pp. 805-810. doi:10.1515/JPEM.2008.21.8.805
|
[22]
|
D. Karantanis, J. M. Durski, V. J. Lowe, M. A. Nathan, B. P. Mullan, E. Georgiou, P. B. Johnston and G. A. Wiseman, “18F-FDG PET and PET/CT in Burkitt’s Lymphoma,” European Journal of Radiology, Vol. 75, No. 1, 2010, pp. e68-e73. doi:10.1016/j.ejrad.2009.07.035
|
[23]
|
K. K. Poh, R. C. Cury, J. Solis, A. J. Fischman, M. J. Wood, “Images in Cardiovascular Medicine. Complementary Role of Multimodality Imaging in the Evaluation of Intracardiac Lymphoma in an HIV-Infected Man,” Circulation, Vol. 115, No. 12, 2007, pp. e339-e341.doi:10.1161/CIRCULATIONAHA.106.664177
|
[24]
|
D. Mioulet, L. Braem, P. Heno, P. Paule, J. M. Peloni, D. Bonnet and L. Fourcade, “Cardiac Extension of a Non-Hodgkin Lymphoma Revealed by an Atrial Flutter,” Annales de Cardiologie et d’Angéiologie, Vol. 58, No. 2, 2009, pp. 117-121. doi:10.1016/j.ancard.2008.05.007
|
[25]
|
E. Abinader and S. Rauchfleisch, “Left Atrial Myoma Presenting with Atrial Tachycardia,” Harefuah, Vol. 105, No. 9, 1983, pp. 263-264.
|
[26]
|
M. Linhart, L. Lickfett, C. Hammerstingl, K. Tiemann, G. Nickenig and T.Lewalter, “Paroxysmal Atrial Flutter Caused by Cardiac Lymphoma,” Pacing and Clinical Electrophysiology, Vol. 29, No. 6, 2006, pp. 682-684.doi:10.1111/j.1540-8159.2006.00419.x
|
[27]
|
M. A. Thompson, A. Harker-Murray, A. J. Lockets and P. Chareonthaitawee, “Unusual Lymphoma Manifestations: Case 2. Myocardial Lymphoma Presenting as Atrial Flutter,” Journal of Clinical Oncology, Vol. 22, No. 3, 2004, pp. 558-560. doi:10.1200/JCO.2004.12.100
|
[28]
|
D.Hayes Jr, D. K. M. Liles and V. L. Sorrell, “An Unusual Cause of New-Onset Atrial Flutter: Primary Cardiac Lymphoma,” Southern Medical Journal, Vol. 96, No. 8, 2003, pp. 799-802. doi:10.1097/01.SMJ.0000054225.89526.BD
|